Search Results - "Mrus, J"

Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta-Analysis by Graham, C. S., Baden, L. R., Yu, E., Mrus, J. M., Carnie, J., Heeren, T., Koziel, M. J.

“…Studies have shown that rates of liver disease are higher in persons who are coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV)…”
Get full text

Efficacy of single-dose 500 mg mebendazole in soil-transmitted helminth infections: a review by Mrus, J, Baeten, B, Engelen, M, Silber, S A

“…Soil-transmitted helminthiasis (STH) is caused by Ascaris lumbricoides (roundworm), Trichuris trichiura (whipworm), and Ancylostoma duodenale and Necator…”
Get more information

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV‐1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily by Zorrilla, CD, Wright, R, Osiyemi, OO, Yasin, S, Baugh, B, Brown, K, Coate, B, Verboven, P, Mrus, J, Falcon, R, Kakuda, TN

“…Objectives Antiretroviral therapy during pregnancy is recommended to reduce the risk of mother‐to‐child transmission of HIV and for maternal care management…”
Get full text

Non-Inferiority of Once-Daily Cobicistat-Boosted Darunavir Versus Ritonavir-Boosted Darunavir in Hiv-1-infected Adult Patients: An Adjusted Comparative Analysis of Pooled Phase 3 Data by Van Sanden, S, Thilakarathne, P, Opsomer, M, Mrus, J, Vanveggel, S, Lathouwers, E, Adriaenssen, I

Get full text

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression by Swindells, Susan, Andrade-Villanueva, Jaime-Federico, Richmond, Gary J, Rizzardini, Giuliano, Baumgarten, Axel, Masiá, Mar, Latiff, Gulam, Pokrovsky, Vadim, Bredeek, Fritz, Smith, Graham, Cahn, Pedro, Kim, Yeon-Sook, Ford, Susan L, Talarico, Christine L, Patel, Parul, Chounta, Vasiliki, Crauwels, Herta, Parys, Wim, Vanveggel, Simon, Mrus, Joseph, Huang, Jenny, Harrington, Conn M, Hudson, Krischan J, Margolis, David A, Smith, Kimberly Y, Williams, Peter E, Spreen, William R

“…Simplified treatment regimens for HIV management may increase adherence. In this open-label, randomized, controlled trial, longer-acting (monthly) injectable…”
Get full text

Cost-Effectiveness of Interventions to Reduce Vertical HIV Transmission from Pregnant Women Who Have Not Received Prenatal Care by Mrus, Joseph M., Tsevat, Joel

“…To evaluate the cost-effectiveness of rapid HIV testing followed by treatmentwith zidovudine, nevirapine, or combination therapy for women presenting in the…”
Get full text

Getting beyond Diagnostic Accuracy: Moving toward Approaches That Can Be Used in Practice by Mrus, Joseph M.

Get full text

Utilities Derived from Visual Analog Scale Scores in Patients with HIV/AIDS by Mrus, Joseph M., Yi, Michael S., Freedberg, Kenneth A., Wu, Albert W., Zackin, Robert, Gorski, Heather, Tsevat, Joel

“…Background. Visual analog scale (VAS) scores are used as global quality-of-life indicators and, unlike true utilities (which assess the desirability of health…”
Get full text

The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy by MRUS, Joseph M, GOLDIE, Sue J, WEINSTEIN, Milton C, TSEVAT, Joel

“…To determine the net health consequences, costs, and cost-effectiveness of alternative delivery strategies for HIV-infected pregnant women with detectable HIV…”
Get full text

Fasting and lactate unmask insulin responsiveness in the isolated working rat heart by Russell, 3rd, R R, Nguyêñ, V T, Mrus, J M, Taegtmeyer, H

“…We have previously reported that the nutritional state in vivo results in differential insulin responses by the perfused heart in vitro. To further assess the…”
Get full text

Compartmentation of hexokinase in rat heart. A critical factor for tracer kinetic analysis of myocardial glucose metabolism by Russell, 3rd, R R, Mrus, J M, Mommessin, J I, Taegtmeyer, H

“…Radiolabeled analogues of 2-deoxyglucose are widely used to trace glucose metabolism in cell cultures, whole organs, and intact animals, although kinetic…”
Get full text

PIN1 - Non-Inferiority of Once-Daily Cobicistat-Boosted Darunavir Versus Ritonavir-Boosted Darunavir in Hiv-1-infected Adult Patients: An Adjusted Comparative Analysis of Pooled Phase 3 Data by Van Sanden, S., Thilakarathne, P., Opsomer, M., Mrus, J., Vanveggel, S., Lathouwers, E., Adriaenssen, I.

Get full text

Efficacy and safety outcomes among treatment-experienced women and men treated with etravirine in gender, race and clinical experience by Hodder, Sally, Jayaweera, Dushyantha, Mrus, Joseph, Ryan, Robert, Witek, James

“…The GRACE (Gender, Race and Clinical Experience) trial enrolled treatment-experienced, HIV-1-infected patients, mainly women, in North America, to assess…”
Get more information

Change in quality of life after being diagnosed with HIV: a multicenter longitudinal study by Tsevat, Joel, Leonard, Anthony C, Szaflarski, Magdalena, Sherman, Susan N, Cotton, Sian, Mrus, Joseph M, Feinberg, Judith

“…The objective of this study was to assess in patients with HIV perceptions of life pre-HIV versus post-HIV diagnosis and examine whether such perceptions…”
Get more information

PIN13 COMPARATIVE COST-EFFICACY ANALYSIS OF DARUNAVIR/R FOR FIRST-LINE TREATMENT OF HIV INFECTION IN THE UNITED STATES by Soorapanth, S, Brogan, A, Mrus, J, Smets, E

Get full text

The costs of full suppression of plasma HIV RNA in highly antiretroviral-experienced patients by Hill, Andrew M, Cho, Michelle, Mrus, Joseph M

“…The aim of antiretroviral treatment is long-term suppression of plasma HIV RNA<50 copies/ml. The DUET, BENCHMRK, and MOTIVATE trials evaluated the efficacy of…”
Get full text

Darunavir outcomes study: comparative effectiveness of virologic suppression, regimen durability, and discontinuation reasons for three-class experienced patients at 48 weeks by Willig, James H, Aban, Inmaculada, Nevin, Christa R, Ye, Jiatao, Raper, James L, McKinnel, James A, Delaitsch, Lori L, Mrus, Joseph M, De La Rosa, Guy R, Mugavero, Michael J, Saag, Michael S

“…Several new antiretroviral (ARV) agents for treatment experienced HIV-infected patients have been approved since June 2006, including darunavir (DRV) and…”
Get more information

Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks by Currier, Judith S, Martorell, Claudia, Osiyemi, Olayemi, Yin, Michael T, Ryan, Robert, De La Rosa, Guy, Mrus, Joseph

“…Gender-based differences in lipids have been noted in antiretroviral clinical trials. We present the metabolic and anthropometric data from the GRACE (Gender,…”
Get more information

Early virologic suppression with three-class experienced patients: 24-week effectiveness in the darunavir outcomes study by MCKINNELL, James A, LIN, Hui-Yi, MUGAVERO, Michael J, SAAG, Michael S, NEVIN, Christa N, WILLIG, James H, MCFARLAND, Graeme, GENZ, Michael, RAPER, James L, DELAITSCH, Lori L, MRUS, Joseph M, KLASKALA, Winslow

“…To evaluate 24-week virologic effectiveness of novel antiretroviral regimens for treatment of three-class experienced adult patients in a clinical practice…”
Get full text

PIN21 CHANGE IN QUALITY OF LIFE AFTER BEING DIAGNOSED WITH HIV by Tsevat, J, Leonard, AC, Szaflarski, M, Sherman, SN, Cotton, S, Mrus, J, Feinberg, J

Get full text